Drug recall
Red Blood Cells (Apheresis)
FDA recall event 65053 · Class II · Central Blood Bank
Key facts
| Event ID | 65053 |
|---|---|
| Recall numbers | B-1760-13 |
| Recalling firm | Central Blood Bank |
| Product type | Biologics |
| Products | Red Blood Cells (Apheresis) |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, which did not undergo the required quality control testing, were distributed. |
| Initiation date | Feb 19, 2013 |
| Report date | Jun 5, 2013 |
| Termination date | May 24, 2013 |
| City | Pittsburgh |
| State | PA |
| Country | United States |
| FEI number | 2571073 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: